Heart attack: Noticed swelling in this body region? You could be at risk of the condition
HEART attack is something one wants to avoid. The condition can be fatal hence medical professionals often highlight the importance of spotting the early warning signs. Swelling in this region is a symptom and should not be ignored.
Conditions: Myocardial Infarction; ST Elevation Myocardial Infarction; Infarction; Necrosis; Heart Disease; Cardiovascular Diseases; Vascular Diseases Interventions: Drug: Everolimus Eluting Coronary Stent System; Device: Cobalt chromium balloon expandable stent (non-drug-eluting stent Arm) Sponsor: Hospital Clinic of Barcelona Completed
In conclusion, the short-term DAPT can reduce the risk of bleeding compared with standard DAPT, without increasing the risk of death or ischemia (Registered by PROSPERO, CRD42020153881). PMID: 32627616 [PubMed - as supplied by publisher]
A HEART ATTACK is a serious subject, but it's not uncommon for people to completely dismiss symptoms as something not to worry about. It's vital you are aware of the symptoms associated with the condition, and one to look out for is in your sweat.
Publication date: August 2020Source: IJC Heart &Vasculature, Volume 29Author(s): Andrea Buono, Enrico Ammirati
Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction. Biomed Res Int. 2020;2020:1276195 Authors: Wang Y, Fu M, Wang J, Zhang J, Han X, Song Y, Fan Y, Hu K, Zhou J, Ge J Abstract The present study is aimed at investigating whether Qiliqiangxin (QL) could regulate myocardial energy metabolism in heart failure rats after acute myocardial infarction (AMI) and further exploring the underlying mechanisms. AMI was established by ligating the left anterior descending coronary ar...
ConclusionsIn this prospective experience in unselected patients with atrial fibrillation, persistence to apixaban was high, and efficacy and safety were comparable to the results in clinical trials, supporting its use in clinical practice.
Publication date: Available online 7 July 2020Source: Journal of Cardiology CasesAuthor(s): Adrienn Tünnemann-Tarr, Stephan Stöbe, Ulrich Laufs, Andreas Hagendorff, Bhupendar Tayal
Conditions: Myocardial Infarction; Coronary Artery Disease; Myocardial Ischemia; Atherosclerosis; Lipid-Rich Atherosclerosis of Coronary Artery; Vascular Diseases; Infarct Ischemia Interventions: Device: Near-infrared spectroscopy (NIRS); Device: Angiography Sponsor: Odense University Hospital Not yet recruiting
Older adults can reduce their risk for a fatal heart attack or stroke by 20 percent by taking a statin. Those over age 75 who were newly prescribed cholesterol-lowering drugs were 25 percent less likely to die.
Authors: Berezin AE, Berezin AA Abstract The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial infarction (AMI) does not decrease regardless of implementation of new technologies supporting opening culprit coronary artery and solving of ischemia-relating stenosis with primary percutaneous coronary intervention (PCI). Numerous studies have examined the diagnostic and prognostic potencies of circulating cardiac biomarkers in acute coronary syndrome/AMI and heart failure after AMI, and even fewer have depicted the utility of biomarkers in AMI patients undergoing primary PCI. Although c...